Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bromhexine hydrochloride for post-exposure prophylaxis against COVID-19
IRCT20120703010178N22Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in coronavirus disease 2019 (COVID-19) comparing Bromhexine hydrochloride with Placebo (2 arms). Primary endpoints: Incidence of COVID-19 disease and COVID-19 disease severity. Started Aug 2020; status: completed.
02
Drugs
bromhexine
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on IRCT20120703010178N22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20120703010178N22.